AGC
GCVRZ

Angelo Gordon & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Angelo Gordon & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,457,600
Closed -$6.98M – 86
2013
Q3 		$6.98M Hold
3,457,600
– – 0.45% 42
2013
Q2 		$6.57M Buy
+3,457,600
New +$6.07M 0.47% 45

Other funds holding GCVRZ

FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Angelo Gordon & Co's GCVRZ Position: Q4 2013 in Review

Angelo Gordon & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2013, closing a stake of 3,457,600 shares — an estimated $6.98M sold.

Angelo Gordon & Co first reported a position in GCVRZ in Q2 2013 and held it in 2 quarters. The position peaked at $6.98M in Q3 2013. 130 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2013.

  • Angelo Gordon & Co reported no remaining Sanofi Contingent Value Rights position as of Q4 2013 after selling out during the quarter.
  • Angelo Gordon & Co sold 3,457,600 Sanofi Contingent Value Rights shares in Q4 2013, an estimated $6.98M.
  • Angelo Gordon & Co first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 2 quarters.
  • Angelo Gordon & Co's Sanofi Contingent Value Rights position peaked at $6.98M in Q3 2013.
  • 130 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2013.

Based on Angelo Gordon & Co's 13F filing for Q4 2013, filed 14 Feb 2014.